Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer
Acta Biochimica et Biophysica Sinica · 2026
DOI: 10.3724/abbs.2025257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2026. Verfasst von Zhouda Cai und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Taipa 999078, Macau, China. Hauptthemen laut MEDLINE: Glycolysis, Drug Resistance, Neoplasm, Prostatic Neoplasms, Membrane Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Taipa 999078, Macau, China.
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
- Institute for Integrative Genome Biology, University of California, Riverside 92507, California, United States.
- School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical…
- Faculty of Medicine, Macau University of Science and Technology, Taipa 999078, Macau, China.
Zitieren
APA
Cai, Z., Lu, J., Mo, S., Liu, J., Zhong, C., Wu, Y., Zou, F., Ye, J., Han, Z., Liang, Y., Zhang, L., Liu, F., & Zhong, W. (2026). Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025257
Vancouver
Cai Z, Lu J, Mo S, Liu J, Zhong C, Wu Y, et al. Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2025257
BibTeX
@article{Cai2026,
author = {Cai, Zhouda and Lu, Jianming and Mo, Shanshan and Liu, Jipu and Zhong, Chuanfan and Wu, Yongding and Zou, Fen and Ye, Jianheng and Han, Zhaodong and Liang, Yuxiang and Zhang, Le and Liu, Fengping and Zhong, Weide},
title = {Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
doi = {10.3724/abbs.2025257}
}
EUVIMED